MétaCan
Menu
Back to cohort
Record W4321375958 · doi:10.3389/fimmu.2023.1086102

VISTA expression and patient selection for immune-based anticancer therapy

2023· review· en· W4321375958 on OpenAlexaff
Alexander S. Martin, Michael Molloy, Andrey Ugolkov, Reinhard W. Von Roemeling, Randolph J. Noelle, Lionel D. Lewis, Melissa L. Johnson, Laszlo Radvanyi, Robert E. Martell

Bibliographic record

VenueFrontiers in Immunology · 2023
Typereview
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsOntario Institute for Cancer Research
FundersNational Heart, Lung, and Blood InstituteEMD SeronoGenentechAstellas PharmaEisaiEQRxY-mAbs TherapeuticsDaiichi Sankyo EuropeCalithera BiosciencesPfizerIncyteG1 TherapeuticsJounce TherapeuticsSyndax PharmaceuticalsBeiGeneMirati TherapeuticsGlaxoSmithKlineTizona TherapeuticsNational Institutes of HealthRegeneron PharmaceuticalsNational Center for Advancing Translational SciencesHelsinnLoxo OncologyRibon TherapeuticsArray BioPharmaExelixisSanofiOncoMed PharmaceuticalRelay TherapeuticsAmgenAstraZenecaEli Lilly and Company
KeywordsImmunotherapyTumor microenvironmentCytotoxic T cellCancer researchImmune systemT cellAntigenMyeloid-derived Suppressor CellImmune checkpointMyeloidCancer immunotherapyBiologyImmunologySuppressorCancerIn vitroGenetics

Abstract

fetched live from OpenAlex

V-domain Ig suppressor of T-cell activation (VISTA) is a B7 family member that plays key roles in maintaining T cell quiescence and regulation of myeloid cell populations, which together establish it as a novel immunotherapy target for solid tumors. Here we review the growing literature on VISTA expression in relation to various malignancies to better understand the role of VISTA and its interactions with both tumor cells and immune cells expressing other checkpoint molecules within the tumor microenvironment (TME). The biology of VISTA creates several mechanisms to maintain the TME, including supporting the function of myeloid-derived suppressor cells, regulating natural killer cell activation, supporting the survival of regulatory T cells, limiting antigen presentation on antigen-presenting cells and maintaining T cells in a quiescent state. Understanding these mechanisms is an important foundation of rational patient selection for anti-VISTA therapy. We provide a general framework to describe distinct patterns of VISTA expression in correlation with other known predictive immunotherapy biomarkers (programmed cell death ligand 1 and tumor-infiltrating lymphocytes) across solid tumors to facilitate investigation of the most efficacious TMEs for VISTA-targeted treatment as a single agent and/or in combination with anti-programmed death 1/anti-cytotoxic T lymphocyte antigen-4 therapies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.326
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations47
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueFrontiers in ImmunologySame topicCancer Immunotherapy and BiomarkersFrench-language works237,207